As we have shown, the death of cells overexpressing βTrCP1 after CIS is due, at least in part, to the retention of the chaperone NPM1 in the nucleoli, caused by an improper and excessive interaction with βTrCP1. Here, BTRC is linked to in situ carcinoma.